02/14/2020
2:13 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/14/2020
11:57 AM | BANK OF AMERICA CORP /DE/ (Filed by)
Concert Pharmaceuticals (Subject)
| Form SC 13G
| |
02/12/2020
9:43 AM | Concert Pharmaceuticals (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
| Form SC 13G
| |
02/10/2020
1:19 PM | BlackRock Inc. (Filed by)
Concert Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/06/2020
12:34 PM | Arkin Moshe (Filed by)
Concert Pharmaceuticals (Subject)
| Form SC 13G
| |
02/05/2020
10:26 AM | BlackRock Inc. (Filed by)
Concert Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/04/2020
10:30 AM | Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2020
3:46 PM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2020
5:13 AM | Concert Pharmaceuticals (Filer)
| Form 424B5
| |
01/23/2020
1:21 PM | Concert Pharmaceuticals (Subject)
INGALLS & SNYDER LLC (Filed by)
| Form SC 13G/A
| |
01/22/2020
8:52 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2019
3:05 PM | Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2019
3:05 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2019
6:06 AM | Concert Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2019
6:03 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2019
5:45 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2019
7:58 AM | Concert Pharmaceuticals (Issuer)
van Heek Christi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2019
3:37 PM | Concert Pharmaceuticals (Issuer)
Munsie Jeffrey A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2019
3:34 PM | Concert Pharmaceuticals (Issuer)
Munsie Jeffrey A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2019
3:01 PM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2019
5:20 AM | Concert Pharmaceuticals (Issuer)
Lynch Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2019
5:18 AM | Becker Marc A. (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2019
5:12 AM | Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2019
3:00 PM | Concert Pharmaceuticals (Issuer)
HUTT PETER BARTON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2019
6:38 AM | Concert Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2019
6:36 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2019
2:31 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
| Form SC 13G/A
| |
06/17/2019
8:14 PM | ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
8:07 PM | Concert Pharmaceuticals (Issuer)
JAEGER WILFRED E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
8:06 PM | Concert Pharmaceuticals (Issuer)
HUTT PETER BARTON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
8:05 PM | Barrett Ronald W (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
8:03 PM | Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
8:02 PM | Concert Pharmaceuticals (Issuer)
van Heek Christi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
8:01 PM | Concert Pharmaceuticals (Issuer)
Hoeiland Jesper (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
3:37 PM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2019
3:16 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Concert Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2019
4:14 PM | Concert Pharmaceuticals (Issuer)
Hoeiland Jesper (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/02/2019
6:27 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2019
6:26 AM | Concert Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2019
6:23 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2019
6:22 AM | Concert Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/24/2019
3:27 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2019
3:34 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2019
3:15 PM | Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2019
2:17 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Concert Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/02/2019
1:50 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
| Form SC 13G/A
| |
03/01/2019
3:43 PM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2019
6:26 AM | Concert Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2019
6:22 AM | Concert Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2019
6:08 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2019
4:17 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
| Form SC 13G
| |
02/07/2019
4:11 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/07/2019
3:35 PM | Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2019
7:46 AM | Concert Pharmaceuticals (Subject)
INGALLS & SNYDER LLC (Filed by)
| Form SC 13G/A
| |
01/08/2019
3:10 PM | Concert Pharmaceuticals (Issuer)
Lynch Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2019
3:09 PM | Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2019
3:08 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2019
3:07 PM | Becker Marc A. (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2019
3:06 PM | Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2018
5:56 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2018
3:08 PM | Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2018
3:00 PM | Concert Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G
| |
11/19/2018
4:27 PM | Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2018
4:22 PM | Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2018
4:21 PM | ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2018
6:33 AM | Concert Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2018
6:28 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2018
6:30 AM | Concert Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2018
6:27 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2018
3:04 PM | Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
6:01 PM | Concert Pharmaceuticals (Issuer)
JAEGER WILFRED E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
6:00 PM | Concert Pharmaceuticals (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
5:59 PM | Concert Pharmaceuticals (Issuer)
HUTT PETER BARTON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
5:58 PM | Concert Pharmaceuticals (Issuer)
Fitzgerald Meghan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
5:57 PM | Barrett Ronald W (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
5:57 PM | Concert Pharmaceuticals (Issuer)
van Heek Christi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
5:56 PM | Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
5:55 PM | ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
3:05 PM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2018
3:56 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2018
6:37 AM | Concert Pharmaceuticals (Filer)
| Form DEF 14A
| |
05/03/2018
6:33 AM | Concert Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2018
6:30 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2018
3:07 PM | Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/13/2018
3:51 PM | Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4/A
| |
04/13/2018
3:50 PM | Concert Pharmaceuticals (Issuer)
HERSCHA LYNETTE (Reporting)
| Form 4/A
| |
04/13/2018
3:47 PM | Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4/A
| |
04/13/2018
3:46 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4/A
| |
04/10/2018
7:00 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2018
3:22 PM | Concert Pharmaceuticals (Issuer)
Lynch Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2018
3:21 PM | Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2018
3:20 PM | Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2018
3:19 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2018
3:06 PM | Concert Pharmaceuticals (Filed by)
Processa Pharmaceuticals, Inc. (Subject)
| Form SC 13G
| |
03/07/2018
11:15 PM | Concert Pharmaceuticals (Filer)
| Form EFFECT
| |
03/05/2018
3:29 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2018
6:41 AM | Concert Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/01/2018
6:38 AM | Concert Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/01/2018
6:34 AM | Concert Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/01/2018
6:31 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
